Selected Publications and Presentations
Lee DW, Rawson JV, Wade SW. Radiology benefit managers (RBMs): Cost Saving or Cost Shifting?
J Am Coll Radiol in press.
Locklear J, Wade S, Palmer L, Jarbrink K, Toghanian S. Real-world treatment patterns and healthcare
resource utilization in generalized anxiety disorder (GAD): a retrospective United States database
analysis. Annual European Congress of the International Society for Pharmacoeconomics and
Outcomes Research (ISPOR), November 2010, Prague, Czech Republic.
Viswanathan H, Wade SW, Curtis JR, Yu J, White J, Stolshek B, Merinar C, Balasubramanian A,
Kallich J, Adams J. Osteoporosis medication adherence and fracture risk among women in a large U.S.
health plan. ACR/ARHP Annual Scientific Meeting, November 2010, Atlanta, GA.
Viswanathan H, White J, Wade SW, Yu J, Curtis JR, Stolshek B, Merinar C, Kallich J,
Balasubramanian A, Adams J. Assessment of incremental cost of osteoporosis-related fractures among
women in a large U.S. managed care population. ACR/ARHP Annual Scientific Meeting, November
2010, Atlanta, GA.
Wade SW, Curtis JR, Yu J, White J, Stolshek B, Merinar C, Balasubramanian A, Kallich J, Adams J,
Viswanathan H. Medication adherence and fracture risk among patients using osteoporosis medications
in a large U.S. health plan. American Society for Bone and Mineral Research Annual Meeting, October
2010, Toronto, Ontario, Canada (poster).
Viswanathan H, White J, Wade SW, Yu J, Curtis JR, Stolshek B, Merinar C, Kallich J,
Balasubramanian A, Adams J. Incremental cost of osteoporosis-related fractures in a large U.S.
managed care population. American Society for Bone and Mineral Research Annual Meeting, October
2010, Toronto, Ontario, Canada (poster).
Lee DW, Rawson JR, Wade S. Radiology benefit managers (RBMs): Cost saving or cost shifting?
Academy Health Annual Research Meeting, June 2010, Boston, MA (poster).
Tosteson ANA, Do T, Wade S, Anthony M, Downs R. Persistence and switching patterns among
women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™.
Osteoporosis Int. 2010 Oct;21(10):1769-80.
Woo C, Gao G, Wade S, Hochberg MC. Gastrointestinal side effects in postmenopausal women using
osteoporosis therapy: 1-year findings in the POSSIBLE US™ Study. Curr Med Res and Opin. 2010
Apr; 26:1003-1009.
Latini DM, Lerner SP, Wade SW, Lee DW, Quale DZ. Bladder cancer detection, treatment and
outcomes: opportunities and challenges. Urology. Feb;75(2):334-9. Epub Dec 4, 2009.
Do T, Wade S, Stewart R, Macarios D, Barrett-Connor E. Impact of Treatment Satisfaction (Perceived
Benefits, Convenience, Side Effects) on Persistence with Postmenopausal Osteoporosis (PMO)
Therapy. American Society for Bone and Mineral Research Annual Meeting, September 2009, Denver,
CO (poster).
Woo C, Gao G, Wade S, Hochberg M. Gastrointestinal Side Effects Associated with Osteoporosis
Therapies Among Postmenopausal: 1-Year Findings From the POSSIBLE US™ Study. North
American Menopause Society Annual Meeting, September 2009, San Diego, CA (poster).
Lukert B, Wade S, Anthony M, Gao G, Downs R. Practice Patterns Among Internists, Family
Practitioners, and Gynecologists in Management of Postmenopausal Osteoporosis (PMO): Results
from POSSIBLE US™. North American Menopause Society Annual Meeting, September 2009, San
Diego, CA (poster).
Woo C, Gao G, Wade S, Hochberg M. Gastrointestinal Side Effects Associated with Osteoporosis
Therapies Among Postmenopausal Women in the United States. American Academy of Nurse
Practitioners Annual Meeting, June 2009, Nashville, TN (poster).
Radiation Therapy: A Cornerstone of Quality Cancer Care. White paper researched and written for
Medical Imaging and Technology Alliance. http://www.medicalimaging.org/
Barrett-Connor E, Ensrud E, Tosteson ANA, Varon SF, Anthony M, Daizadeh N, Wade S. Design of
the POSSIBLE US Study: postmenopausal women’s compliance and persistence with osteoporosis
medications. Osteoporosis Int. 2009 Mar;20(3):463-72.
Tosteson ANA, Wade S, Anthony M, Brancato C, Nichols S, Downs RW. Correlates of osteoporosis
treatment persistence for patients new to therapy and patients with recent switches: 6-month results
from POSSIBLE US. American Society for Bone and Mineral Research Annual Meeting, September
2008, Montreal, Canada (poster).
Woo C, Gao G, Wade S, Hochberg M. Gastrointestinal side effects in postmenopausal U.S. women on
osteoporosis therapy: 6-month findings from the POSSIBLE US Study. American Society for Bone
and Mineral Research Annual Meeting, September 2008, Montreal, Canada (poster).
Do T, Wade S, Anthony MS, Wagman RB, Downs RW. Medication switching in postmenopausal
women on osteoporosis therapy: 6-month findings from the POSSIBLE US Study. American Society
for Bone and Mineral Research Annual Meeting, September 2008, Montreal, Canada (poster).
The Value of Imaging: Improving Outcomes and Reducing Costs. White paper researched and written
for Medical Imaging and Technology Alliance. http://www.medicalimaging.org/
Barrett-Connor E, Zagari M, Wade S, Ryu S, Fitzpatrick LA. Design of the prospective observational
study of osteoporosis medication use in postmenopausal women in the US. American Society for Bone
and Mineral Research Annual Meeting, September 2006, Philadelphia, PA (poster).
Ensrud K, Barrett-Connor E, Tosteson A, Wade S, Farivar S, Fitzpatrick LA. Pattern of use of
osteoporosis therapies in postmenopausal women: baseline results of POSSIBLE US. American
Society for Bone and Mineral Research Annual Meeting, September 2006, Philadelphia, PA (poster).
Wade SW, Magee, G, Metz L, Broder MS. Cost-effectiveness of treatments for dysfunctional uterine
bleeding. J Reprod Med. 2006 Jul;51(7):553-62.
Nissenson, A, Wade S, Goodnough LT, Knight, K, Dubois R. Economic burden of anemia in an
insured population. J Manag Care Pharm. 2005 Sep;11(7):565-74.
Dubinsky MC, Reyes E, Ofman J, Chiou CF, Wade S, Sandborn WJ. A cost-effectiveness
analysis of alternative disease management strategies in patients with Crohn’s disease treated
with azathioprine or 6-mercatopurine. Am J Gastroenterol. 2005 Oct;100(10):2239-47.
Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating direct and indirect costs of premenstrual
syndrome. J Occup Environ Med. 2005;47:26-33.
Peabody JW, Schau B, Lopez-Vidriero M, Vestbo J, Wade S, Iqbal A. COPD: a prevalence estimation
model. Respirology. 2005 Nov;10(5):594-602.
Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of
the literature. Am J Med. 2004;116:11S-26S.
Wilson A, Longstreth GF, Knight K, Wong J, Wade S, Chiou CF, Barghout V, Frech F, Ofman JJ.
Quality of life in managed care patients with irritable bowel syndrome. Manag Care Interface.
2004;17:24-28,34.
Wade SW, Knight K, Wilson A, Dubois R, Goodnough LT, Nissenson AR “The Economic Burden of
Anemia in an Insured Population,” International Society for Pharmacoeconomics and Outcomes
Research (ISPOR) Annual International Meeting, May, 2004, Arlington, VA (poster).
Borenstein J, Yu HT, Wade S, Chiou CF, Rapkin A. Effect of an oral contraceptive containing ethinyl
estradiol and drospirenone on premenstrual symptomatology and health-related quality of life. J Reprod
Med. 2003;48:79-85.
Ofman JJ; Sullivan SD; Neumann PJ; Chiou CF; Henning JM; Wade SW; Hay JW. Examining the
value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care
Pharm. 2003;9:53-61.
London R, Solis A, Goldberg GA, Wade S, Chan WW. Examination of resource use and clinical
interventions associated with chronic kidney disease in a managed care population. J Manag Care
Pharm. 2003 May-Jun;9(3):248-55.
Gilberg K, Laouri M, Wade S,Isonaka S,. Analysis of medication use patterns:apparent overuse of
antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J Manag Care Pharm.
2003 May-Jun;9(3):232-7.
Tesser J, Gluck O, Lawless G, Wade S, Kadlubek P. “Healthcare Resource Utilization Attributed to
Infections in Patients with Rheumatoid Arthritis.” European League Against Rheumatism, European
Congress Of Rheumatology, June 2003, Stockholm (Poster).
Dubois RW, Batchlor E, Wade S. Geographic Variation in the Use of Medications: Is Uniformity
Good News or Bad? Health Affairs. 2002;21(1):240-250.
Halbert RJ, Zaher C, Wade S, Malin J, Lawless G, Dubois R. Outpatient Cancer Drug Costs. Cancer.
February 15, 2002; 94(4): 1142-1150.
Arocho R, Solis A, Wade S, Goldberg G, Tang S. Exploring the methodological challenges of
investigating comparison groups with different underlying characteristics: a case study. J Manag Care
Pharm. 2002;5:353-359.
Dubois RW, Alexander CM, Wade S, Mosso A, Markson L, Nag S, Berger ML. Growth in use of lipid
lowering therapies: are we targeting the right patients? Am J Manag Care. 2002;8:862-867.
London R, Solis A, Goldberg GA, Wade S, Ryu S. Health care resource utilization and the impact of
anemia management in patients with chronic kidney disease. Am J Kidney Dis. 2002 Sep;40(3):539-48.
Chiou CF, Wilson A, Longstreth G, Wade S, Wong J, Barghout V, Frech F, Ofman J. “The
Relationship Between Irritable Bowel Syndrome, Abdominal Pain/Discomfort, and Indirect Costs.”
Digestive Disease Week Annual Meeting, May 2002, San Francisco, CA (poster).
Knight K, Reyes E, Wallace J, Chiou CF, Wade S, Borenstein J. “Cost-Effectiveness Analysis of
Long-Term Contraceptive for Women.” International Society for Pharmacoeconomics and Outcomes
Research (ISPOR) Annual Meeting, May 2002, Arlington, VA (poster).
Wade SW, Berzon R, Patton MP, Koch P, Batra D. “Patterns of Antidepressant Use and Health Care
Costs in Depressed Patients Who Received SSRI Therapy.” International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, May 2001, Arlington, VA
(poster).
Gluck O, Tesser J, Lawless G, Wade SW, Goldberg GA, Batra D, Kadlubek P. “Incidence Of
Clinically Relevant Infections Associated With Rheumatoid Arthritis (Ra) Therapies.” European
League Against Rheumatism, European Congress Of Rheumatology, June 2001, Prague, Czech
Republic (poster).
London R, Goldberg GA, Wade SW. “Comparative Resource Use For Erythropoietin (Epo) Users
And Non-Users During Pre-Dialysis.” National Kidney Foundation Clinical Nephrology Meeting,
April 2001, Orlando FL (poster).
London R, Goldberg GA, Solis A, Wade SW. “Resource Utilization Pattern Of Patients During
Pre-Dialysis.” National Kidney Foundation Clinical Nephrology Meeting, April 2001, Orlando
FL (poster).
Cummings J, Duttagupta S, Wade SW, Goldberg GA, Mosso A, Patton M, Haberman M. “Cost
Savings Associated With Use Of Donepezil In Managed Care.” American Association of
Geriatric Psychiatry Annual Meeting, February 2001, San Francisco, CA (poster).
Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade SW. Explaining Drug Spending
Trends: Does Perception Match Reality? Health Affairs, 2000;19:231-239.